Quantcast Acelity - INFOV.A.C.™ Negative Pressure Wound Therapy System
MENU

INFOV.A.C.™ Negative Pressure Wound Therapy System


INFOV.A.C.™ Therapy Unit
INFOV.A.C.™ Therapy Unit
INFOV.A.C.™ Therapy System
INFOV.A.C.™ Therapy System

Negative Pressure Wound Therapy for Acute Care

The INFOV.A.C.™ Therapy System is designed to make V.A.C.® Therapy simple and informative.

Overview

Easy to Use

The INFOV.A.C.™  Therapy System is designed to make V.A.C.® Therapy simple while delivering positive outcomes you trust.

SENSAT.R.A.C.™ with EASYCLEAR™ Purge Technology

Only V.A.C.® Therapy provides patented SENSAT.R.A.C.™ Technology, a real-time pressure feedback system that adjusts pump output, compensating for wound distance, wound position, exudates characteristics, and patient movement

Customized Therapies

Along with managing wounds, the INFOV.A.C.® Therapy System can help manage the open abdomen when using the ABTHERA™ SENSAT.R.A.C.™ Open Abdomen Dressing Kit. It can also help manage closed surgical incisions when using a PREVENA™ Incision Management Dressing with its V.A.C.® Therapy Unit connector.

How it Works

  • About
  • Specifications
  • Materials For Download

About

V.A.C.® Therapy creates an environment that promotes wound healing

The mechanisms of action for V.A.C.® Therapy include drawing wound edges together, removing infectious materials and wound fluids, promoting perfusion, maintaining a closed, moist wound healing environment and promoting granulation tissue formation.

The integrated V.A.C.® Therapy System has a unique mechanism of action whereby the delivery of negative pressure through the V.A.C.® Therapy units using proprietary V.A.C.® GRANUFOAM™ Dressings maintains a wound environment that promotes wound healing.

 

How V.A.C.® Therapy creates an environment that promotes wound healing

Under negative pressure, V.A.C.® Therapy with proprietary V.A.C.® GRANUFOAM™ Dressings applies mechanical forces to the wound to create an environment that promotes wound healing. These forces are known as macrostrain and microstrain.1
 
Macrostrain is the visible stretch that occurs when negative pressure contracts the foam.
  • Draws wound edges together
  • Provides direct and complete wound bed contact
  • Evenly distributes negative pressure
  • Removes exudate and infectious materials
 
Microstrain is the microdeformation at the cellular level, which leads to cell stretch.
  • Reduces edema
  • Promotes perfusion
  • Promotes granulation tissue formation by facilitating cell migration and proliferation
 

Specifications

INFOV.A.C. Therapy Unit
Weight:                   6.4lbs (2.9kg) with 500ml canister
Dimensions:            23 x 17 x 17cm (9.05 x 6.69 x 6.69in)
Battery Type:          Lithium ion rechargeable battery
Battery Life:            6 hour average
Canister Volume:    500 and 1,000ml
 
Therapy Delivery
Modes:                     Continuous or Intermittent
Intensity Settings:   Low, Medium, High
Pressure Settings:   -25mmHg through –200mmHg (-3.3kPa to -26.6kPa)
 
Electrical Data
Voltage:                   100-240V
Frequency:              50Hz-60Hz
Power:                     60W
Power Supply:         Class I Equipment
 
IEC Classification
Continuous Operation
Type B Equipment
Class II or internally powered Equipment
Ordinary Equipment
Equipment not suitable for use in the presence of a flammable anesthetic mixture with air, oxygen or nitrous oxide
 
Environmental Conditions
Storage Temperature Range:         -10°C to +50°C
Operational Temperature Range:   +10°C to +30°C
Relative Humidity Range:                10% to 85% non-condensing
Barometric Pressure Range:            700hPa to 1060hPa
 

Indications & Applications

Indications & Applications

  • Indications
  • Applications

Indications for Use

Before use, physicians should review complete risk information and essential prescribing information which can be found in the Instructions for Use
 
The INFOV.A.C. Therapy System is an integrated wound management system for use in acute, extended and home care settings. It is intended to create an environment that promotes wound healing by secondary or tertiary (delayed primary) intention by preparing the wound bed for closure, reducing edema, promoting granulation tissue formation and perfusion, and by removing exudate and infectious material. It is indicated for patients with chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic, venous insufficiency or pressure), flaps and grafts. When used on closed surgical incisions, it is intended to manage the environment of surgical incisions that continue to drain following sutured or staple closure by maintaining a closed environment and removing exudates via the application of negative pressure wound therapy.
 

Evidence & Outcomes

V.A.C.® Therapy has the largest body of evidence to date including over 1,000 peer reviewed articles, 45 of which are randomized controlled trials (RCTs). These studies have demonstrated positive clinical outcomes of NPWT, as well as the effectiveness of V.A.C.® Therapy in diabetic foot wounds, chronic wounds (e.g., pressure ulcers and lower extremity ulcers), and a variety of acute wounds. Some of these studies are listed below.

Clinical Evidence

Additional summary of evidence and outcomes.

Evidence & Outcomes

Product Evidence and Outcomes

Title Study Type Date Authors